Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study
Journal
International journal of chronic obstructive pulmonary disease
Journal Volume
17
Pages
285
Date Issued
2022
Author(s)
Abstract
Pioglitazone's effect on chronic obstructive pulmonary disease (COPD) has rarely been studied.
Subjects
Taiwan; chronic bronchitis; emphysema; pharmacoepidemiological study; risk factors; thiazolidinediones
SDGs
Publisher
DOVE MEDICAL PRESS LTD
Type
journal article